PL315513A1 - Application of il-10 for cytolytical activity stimulation of mononuclear peripheral blood cells - Google Patents

Application of il-10 for cytolytical activity stimulation of mononuclear peripheral blood cells

Info

Publication number
PL315513A1
PL315513A1 PL94315513A PL31551394A PL315513A1 PL 315513 A1 PL315513 A1 PL 315513A1 PL 94315513 A PL94315513 A PL 94315513A PL 31551394 A PL31551394 A PL 31551394A PL 315513 A1 PL315513 A1 PL 315513A1
Authority
PL
Poland
Prior art keywords
cytolytical
application
blood cells
peripheral blood
activity stimulation
Prior art date
Application number
PL94315513A
Other versions
PL175343B1 (en
Inventor
Martin A Schwarz
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PL315513A1 publication Critical patent/PL315513A1/en
Publication of PL175343B1 publication Critical patent/PL175343B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the cancer treated
    • A61K2239/48—Blood cells, e.g. leukemia or lymphoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
PL94315513A 1994-01-20 1994-01-20 Application of il-10 for cytolytical activity stimulation of mononuclear peripheral blood cells PL175343B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN94194863A CN1142186A (en) 1994-01-20 1994-01-20 Cytolytic activity of peripheral blood mononuclear cells activated by interleukin-10
PCT/IB1994/000008 WO1995019780A1 (en) 1994-01-20 1994-01-20 Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity

Publications (2)

Publication Number Publication Date
PL315513A1 true PL315513A1 (en) 1996-11-12
PL175343B1 PL175343B1 (en) 1998-12-31

Family

ID=37708148

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94315513A PL175343B1 (en) 1994-01-20 1994-01-20 Application of il-10 for cytolytical activity stimulation of mononuclear peripheral blood cells

Country Status (10)

Country Link
EP (1) EP0740552A1 (en)
JP (1) JPH09508116A (en)
CN (1) CN1142186A (en)
AU (1) AU707019B2 (en)
FI (1) FI962813A0 (en)
NO (1) NO963029L (en)
NZ (1) NZ259584A (en)
PL (1) PL175343B1 (en)
SK (1) SK91696A3 (en)
WO (1) WO1995019780A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037096A2 (en) * 1998-12-22 2000-06-29 Schering Corporation Treatment of hepatitis c virus infections with interleukin-10
EP2295450B1 (en) 2000-09-29 2015-01-28 Merck Sharp & Dohme Corp. Pegylated interleukin-10
RU2322452C2 (en) * 2006-03-27 2008-04-20 Михаил Николаевич Смирнов Immunomodulating composition
EP2066336B1 (en) 2006-09-28 2012-09-19 Merck Sharp & Dohme Corp. Use of pegylated il-10 to treat cancer
US20110044939A1 (en) * 2007-06-27 2011-02-24 Joslin Diabetes Center, Inc. Regulatory t cells in adipose tissue
ES2655364T3 (en) 2008-12-17 2018-02-19 Merck Sharp & Dohme Corp. Production of mono- and dipegilated IL-10 and its uses
MX2015014438A (en) 2013-04-18 2016-05-18 Armo Biosciences Inc Methods of using interleukin-10 for treating diseases and disorders.
EP3010527B1 (en) 2013-06-17 2018-08-08 Armo Biosciences, Inc. Method for assessing protein identity and stability
CN105658232A (en) 2013-08-30 2016-06-08 阿尔莫生物科技股份有限公司 Methods of using interleukin-10 for treating diseases and disorders
CN120242030A (en) 2013-11-11 2025-07-04 阿尔莫生物科技股份有限公司 Methods of using interleukin-10 to treat diseases and conditions
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
WO2016060996A2 (en) 2014-10-14 2016-04-21 Armo Biosciences, Inc. Interleukin-15 compositions and uses thereof
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US20160361415A1 (en) 2015-05-28 2016-12-15 Armo Biosciences, Inc. Methods of Using Interleukin-10 for Treating Diseases and Disorders
KR20180038553A (en) 2015-08-25 2018-04-16 아르모 바이오사이언시스 인코포레이티드 Methods for using interleukin-10 to treat diseases and disorders
WO2023072863A1 (en) * 2021-10-25 2023-05-04 Ellennbe Gmbh Pharmaceutical composition and kit comprising an immunomodulatory substance for treating diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE116550T1 (en) * 1991-01-16 1995-01-15 Schering Corp TREATMENT OF NEOPLASTIC DISEASES WITH INTERLEUKIN-10.
ES2074879T3 (en) * 1991-01-16 1995-09-16 Schering Corp USE OF INTERLEUKIN-10 IN ADOPTIVE CANCER IMMUNOTHERAPY.
US5055045A (en) * 1991-03-18 1991-10-08 Dickie Robert G Disposable dental matrix retainer clamp

Also Published As

Publication number Publication date
FI962813A7 (en) 1996-07-11
JPH09508116A (en) 1997-08-19
FI962813L (en) 1996-07-11
NZ259584A (en) 1998-01-26
AU5842594A (en) 1995-08-08
NO963029L (en) 1996-09-19
AU707019B2 (en) 1999-07-01
SK91696A3 (en) 1997-04-09
PL175343B1 (en) 1998-12-31
FI962813A0 (en) 1996-07-11
WO1995019780A1 (en) 1995-07-27
CN1142186A (en) 1997-02-05
NO963029D0 (en) 1996-07-19
EP0740552A1 (en) 1996-11-06

Similar Documents

Publication Publication Date Title
PL315513A1 (en) Application of il-10 for cytolytical activity stimulation of mononuclear peripheral blood cells
GB8524455D0 (en) Monitoring activity of peripheral devices
EP0161770A3 (en) Lysing agent for analysis of peripheral blood cells
ZW18986A1 (en) Collection of human body discharge
HU9502918D0 (en) Pharmaceutical composition of antihypertriglyceridemic activity
PH22293A (en) Thienopyridone compounds and compositions with therapeutic activity
FI953186A7 (en) Assessment of bone cell activity
PL327732A1 (en) Compounds of therapeutic activity
PL336760A1 (en) Treatment of skin diseases
IL75828A0 (en) Immobilization of biologically active substances
ZA94212B (en) Use of IL-10 to stimulate peripheral blood mononuclear cell cytolytic activity
ZA935647B (en) Treatment of sickle cell disease
GB2189144B (en) Zinc complex of 5-chloro-7-iodo-8hydroxyquinoline having antimycotic activity and therapeutic use thereof.
AU8398398A (en) Modification of nitric oxide activity to treat fas-induced pathologies
HU9601989D0 (en) Use of il-10 to stimulate peripheral blood mononuclear cell cytolytic activity
GB9721075D0 (en) Materials and methods relating to the stimulation of cells
GB2200284B (en) Electrode for skin treatment
PL311885A1 (en) Protein of tpo activity
AU2604895A (en) Short-term anti-cd3 stimulation of lymphocytes to increase their (in vivo) activity
AU8999298A (en) Protein having activity of activiting nerve cell functions
EP0576862A3 (en) Dna for immortalisation of human or animal cells
GB2275780B (en) Methods of measuring and controlling activity of zinc phosphate treatment solution
CS116086A1 (en) Agent with biological and bactericidal activity
AU586029B2 (en) Collection of human body discharge
HUT74175A (en) Lysozime-containing combined products of antimicrobial activity for human therapy